Progression of Mycosis Fungoides After Fingolimod Treatment for Multiple Sclerosis and Targeted Next-Generation Sequencing Demonstrating Potential Links Between the Two Diseases.

Narala, Saisindhu; Che, Yonglu; Saleem, Atif; Lock, Christopher B; Kim, Youn H; Rieger, Kerri E

Narala, Saisindhu; Che, Yonglu; Saleem, Atif; Lock, Christopher B; Kim, Youn H; Rieger, Kerri E.

Afiliação

Narala S; Department of Pathology, Stanford University School of Medicine, Stanford, CA.
Che Y; Department of Dermatology, Stanford University School of Medicine, Stanford, CA.
Saleem A; Department of Dermatology, Stanford University School of Medicine, Stanford, CA.
Lock CB; Department of Pathology, Stanford University School of Medicine, Stanford, CA.
Kim YH; Division of Neuroimmunology, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA.
Rieger KE; Department of Dermatology, Stanford University School of Medicine, Stanford, CA.

JCO Precis Oncol ; 7: e2200501, 2023 02.

Article em En | MEDLINE | ID: mdl-36724412

Assuntos

Esclerose Múltipla; Micose Fungoide; Neoplasias Cutâneas; Humanos; Cloridrato de Fingolimode/efeitos adversos; Esclerose Múltipla/tratamento farmacológico; Esclerose Múltipla/genética; Micose Fungoide/tratamento farmacológico; Micose Fungoide/genética; Neoplasias Cutâneas/tratamento farmacológico; Neoplasias Cutâneas/genética; Sequenciamento de Nucleotídeos em Larga Escala

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Micose Fungoide / Esclerose Múltipla Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google